Inventor · disambiguated record
Atwood Kim Cheung
Also filed as: CHEUNG ATWOOD · CHEUNG ATWOOD K · CHEUNG ATWOOD KIM
14 granted patents·7 pending applications·99 citations·filing 2004–2024
91Inventor score
Top patents by PatentIndex Score
21 records- 0194US10195196B21,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditionsNOVARTIS AG·Filed 2016·Granted Feb 5, 2019·15 cites·9 claims
- 0294US8729263B21,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditionsCHEUNG ATWOOD KIM·Filed 2013·Granted May 20, 2014·45 cites·5 claims
- 0391US11708366B2Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereofNOVARTIS AG·Filed 2021·Granted Jul 25, 2023·2 cites·27 claims
- 0491US9545404B21,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditionsNOVARTIS AG·Filed 2014·Granted Jan 17, 2017·16 cites·10 claims
- 0587US10758533B21,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditionsNOVARTIS AG·Filed 2019·Granted Sep 1, 2020·2 cites·8 claims
- 0685US8211929B2Pyrimidine derivatives as kinase modulators and method of useCHEN JEFF·Filed 2005·Granted Jul 3, 2012·11 cites·7 claims
- 0779US9181266B22-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitorsCHEUNG ATWOOD KIM·Filed 2012·Granted Nov 10, 2015·3 cites·13 claims
- 0879US2025092042A1Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0977US12157737B2Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereofNOVARTIS AG·Filed 2023·Granted Dec 3, 2024·0 cites·16 claims
- 1077US2022387428A11,4-disubstituted pyridazine analogs there of and methods for treating smn-deficiency-related conditionsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1177US2024009189A11,4-disubstituted pyridazine quinolne analogs there of and methods for treating smn-deficiency-related conditionsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1274US12129246B1Hydroquinazoline derivatives for the treatment of a disease or disorderNOVARTIS AG·Filed 2024·Granted Oct 29, 2024·0 cites·30 claims
- 1372US11229648B21,4-disubstituted pyridazine analogs thereof and methods for treating SMN-deficiency-related conditionsNOVARTIS AG·Filed 2020·Granted Jan 25, 2022·0 cites·24 claims
- 1471US2025214989A1Naphthyridinone derivatives for the treatment of a disease or disorderNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1570US12084442B2Naphthyridinone derivatives for the treatment of a disease or disorderNOVARTIS AG·Filed 2022·Granted Sep 10, 2024·0 cites·21 claims
- 1669US2024391941A1Naphthyridinone derivatives for the treatment of a disease or disorderNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1767US8013156B2Tie-2 modulators and methods of useEXELIXIS INC·Filed 2004·Granted Sep 6, 2011·4 cites·26 claims
- 1866US11672799B21,4-disubstituted pyridazine quinolne analogs there of and methods for treating SMN-deficiency-related conditionsNOVARTIS AG·Filed 2019·Granted Jun 13, 2023·0 cites·9 claims
- 1966US9227982B24-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrminidinyl compounds for use as tankyrase inhibitorsCHEUNG ATWOOD KIM·Filed 2012·Granted Jan 5, 2016·1 cites·13 claims
- 2057US2016184305A11,4-disubstituted pyridazine quinolne analogs there of and methods for treating smn-deficiency-related conditionsCHEUNG ATWOOD·Filed 2014·Application pending·0 cites
- 2148US2010267626A1Methods and compositions for measuring wnt activation and for treating wnt-related cancersNOVARTIS AG·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Atwood Kim Cheung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →